An association of decreased levels of Drebrin with deterioration of spines and synapses was reported in the hippocampal synapses [32,33] and brains [32,33] of patients with Alzheimer's disease (AD) as well as in Aβ peptide-treated hippocampal neurons [34]. This evidence concerns the gene DBN1 and early-onset autosomal dominant Alzheimer disease.